* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Chronic anxiety in ICD patients: A multi
Emergency psychiatry wikipedia , lookup
Separation anxiety disorder wikipedia , lookup
History of psychiatric institutions wikipedia , lookup
Abnormal psychology wikipedia , lookup
Generalized anxiety disorder wikipedia , lookup
International Statistical Classification of Diseases and Related Health Problems wikipedia , lookup
CoRPS WEB-based distress management program for implantable CARdioverter dEfibrillator patients (WEBCARE) Susanne S. Pedersen, Professor of Cardiac Psychology Center of Research on Psychology in Somatic diseases CoRPS Project participants CoRPS • Susanne S. Pedersen (PI; PhD) • Viola Spek (Project leader; PhD) • Krista van den Broek (PhD) • Johan Denollet (PhD) • Mirela Habibovic (MSc) Erasmus Medical Center, Rotterdam • Luc Jordaens (MD, PhD) • Dominic Theuns (PhD) • Agnes Muskens-Heemskerk Amphia Hospital, Breda • Marco Alings (MD, PhD) Catharina Hospital, Eindhoven • Pepijn van der Voort (MD) Free University, Amsterdam • Pim Cuijpers (PhD) STIN (Stichting ICD dragers Nederland) • Peter Zaadstra (Projectadvisor) Funding agency • The Netherlands Organisation for Health Research and Development, the Hague ZonMw (grant no. 300020002) CoRPS Overview • Background • Objectives of WEBCARE • WEBCARE – Patient population – Design – Measures – Intervention CoRPS Overview • Background • Objectives of WEBCARE • WEBCARE – Patient population – Design – Measures – Intervention CoRPS CoRPS Rise in ICD implantations 2002 MADIT-II 2000 CRT-D 2004 SCD-HeFT 1997/8 Number of Worldwide ICD Implants Per Year DC-ICD COMPANION 90.000 1980 1989 800,000 heart patients First Human in Europe and 1 mill in Implant 1985 North America have a cardiovascular implantable FDA Approval of electronic device 80.000 70.000 60.000 •Transvenous Leads •Biphasic Waveform ICDs 50.000 40.000 AVID CASH CIDS 1993 Smaller Devices 1999 MUSTT 1988 30.000 Tiered Therapy 20.000 1996 MADIT 10.000 0 1980 1985 1990 Crespo et al. Am J Med Sci 2005;329:238-46 1995 2000 2005 What is an implantable cardioverter CoRPS defibrillator (ICD)? • The ICD can shock with up to 700800 volts • “It’s like getting kicked in the chest by a big horse!” CoRPS ICD therapy: Benefits and side effects Epstein, J Am Coll Cardiol 2008 CoRPS ICD therapy: Benefits and side effects • Complications (lead fractures, dislodgement, and infection) • Shocks that are inappropriate mortality risk ? • Potential malfunctioning, as notified with a device recall • Significant anxiety and depression in 20-30% of patients • Patient´s psychological reaction to the device may increase the risk of arrhythmias Risk that patients will refuse this potentially life-saving treatment Tung et al. JACC 2008; Pedersen et al. PACE 2009;32:1006-11 Versteeg.... & Pedersen. PACE, 2009 Aug 21. [Epub ahead of print] CoRPS Continuum of shock response Shock continuum No shocks Cumulative shocks ICD storms Anxiety spectrum Normalised fear Shock phobias (e.g. exertion) Generalised anxiety PTSD Thoughts and behaviors “The ICD keeps me safe during exertion” “The ICD is my reason for not exerting” Sears et al. Heart 2002 “There is very little that I am safe to do with my ICD” “The ICD does not keep me safe” CoRPS Distress and arrhythmias Mood states also predict arrhythmic events: – Mood disturbance (OR: 1.14-1.16) 3 mths and 6 mths arrhythmia – 15 min prior to shocks, independent effects of anger, (OR: 1.83), and mild-to-moderate physical activity (OR: 1.46); no effect for anxiety, worry, sadness, happiness, challenge, interest, and in control Dunbar et al. Depress Anxiety 1999; Lampert et al. Circulation 2002 CoRPS Distress and arrhythmias – Depression: HR: 3.2 - time to first shock for VT/VF; HR: 3.2 – all shocks for VT/VF including recurrent episodes (adjusted analysis) – Anxious Type D’s: HR: 1.72 (95% CI: 1.03 to 2.89) 1 year ventricular arrhythmias, independent of sex, age, ischemic etiology, left ventricular dysfunction, prolonged QRS duration, and medication); no effect for anxiety and depressive symptoms Whang et al. JACC 2005; van den Broek et al. JACC 2009 CoRPS ICD shocks - the paradox Structural heart disease Electrical instability Autonomic imbalance HR HRV Inflammation Distress (Anxiety / Depression) Danger? Safety? Tachyarrhythmia / shock Increased perception, dysfunctional appraisal, maladaptive coping Personality Pre-existing distress Social support CoRPS Intervention in ICD patients Pedersen, van den Broek, & Sears. PACE 2007 CoRPS Four new studies added... Authors N (design) FU-period Outcome Dunbar 246 (RCT) 12 mths anxiety; depression; health care consumption and disability days Kuhl 30 (RCT) 1 mth no change in knowledge perception Lewin 192 (RCT) 6 mths anxiety; depression; admissions; QoL Sears 30 (RCT) 4 mths anxiety; cortisol depression in 1-day workshop group Dunbar et al. PACE 2009; Kuhl et al. J Cardiovasc Nursing 2009; Lewin et al. Heart 2009; Sears et al. PACE 2007 CoRPS Overview • Background • Objectives of WEBCARE • WEBCARE – Patient population – Design – Measures – Intervention CoRPS OBJECTIVES Primary: • To investigate whether the web-based intervention is superior to usual care in terms of reducing anxiety, depression, and ICD concerns as well as improving ICD acceptance and QoL • To investigate the cost-effectiveness of the web-based intervention and whether the web-based intervention is associated with reduced health-care utilization CoRPS Secondary: • To examine whether psychological (i.e., Type D personality and positive affect) and clinical factors (i.e., cardiac resynchronization therapy (CRT)) moderate the effect of the intervention, with a view to developing risk profiles of patients who are less likely to benefit from the intervention Explorative: • To explore whether the web-based intervention influences physiological parameters (i.e., ventricular arrhythmias and the cortisol awakening response (CAR)) CoRPS Overview • Background • Objectives of WEBCARE • WEBCARE – Patient population – Design – Measures – Intervention CoRPS Patient population Consecutive ICD patients recruited from 3 centers: ₋ Amphia Hospital, Breda ₋ Catharina Hospital, Eindhoven ₋ Erasmus Medical Center, Rotterdam CoRPS Power analysis based on the assumptions : – expected between group effect size of .30 – alpha = 0.05 – power = 0.80 (two-sided test) – 350 patients are needed (i.e., 175 in each condition). Given an expected response rate of 50% (earlier study = 82%) 700 patients need to be approached Pedersen et al. Psychosom Med 2004 CoRPS Inclusion criteria • • • • • Patients implanted with an ICD 18-75 years of age Speaking and understanding Dutch With access to and ability to use the internet Providing written informed consent CoRPS Exclusion criteria • A life expectancy less than 1 year • A history of psychiatric illness other than affective/anxiety disorders • On the waiting list for heart transplantation • With insufficient knowledge of the Dutch language CoRPS Study design 5-10 days post implantation: completion of baseline questionnaire -T1 T0 Follow-up Intervention T1 T2 T3 14 26 52 Usual care Weeks 0 Hospitalisation for ICD implantation 2 Randomisation to intervention or usual care CoRPS Self-report measures Construct Anxiety Questionnaire T0 T1 T2 T3 STAI-S State Trait Anxiety Inventory (state only) x x x x FSAS Florida Shock Anxiety Scale x x x x PDS Posttraumatic Stress Disorder Scale x x x DAI-5 Denollet Anxiety Inventory x x x x HADS Hospital Anxiety and Depression Scale x x x x PHQ-9 Patient Health Questionnaire x x x x SF-12 Short Form Health Survey 12 x x x x MLWHFQ Minnesota Living With Heart Failure Questionnaire x x x x ICD concerns ICDC ICD Patient Concerns Questionnaire x x x x ICD acceptance FPAS Florida Patient Acceptance Survey x x x x Health care utilization and cost-effectiveness TiC-P Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness x Type D personality DS14 Type D Scale x Depressive symptoms Quality of life T0 = Baseline; T1 = 14 weeks; T2 = 26 weeks; T3 =52 weeks x x x x CoRPS Physiological measures • Salivary cortisol, using the Salivette, assessed at 3 out of the 4 time points (i.e., T0 = 5 to 10 days after ICD implantation; T1 = 14 weeks post-implantation; T3 = 52 weeks post-implantation) • Four samples will be taken at each time point and on the consecutive day, that is (a) when waking up, (b) ½ hour later, (c) 11.00 a.m., and (d) 3.00 p.m. CoRPS Other measures • Clinical: ICD indication, etiology, LVEF, CRT, comorbidity, type of ICD therapy (ATP vs. shock; appropriate vs. inappropriate), QRS-complex, cardiac medication, etc. • Demographic: Sex, age, marital status, education, working status • Other: Smoking status, participation in cardiac rehabilitation since ICD implantation, the use of psychotropic medication, help-seeking from a psychologist/psychiatrist CoRPS Study endpoints Primary: • Anxiety; depression; ICD concerns; ICD acceptance; quality of life; health care utilization; costeffectiveness of the intervention Secondary: • Ventricular arrhythmias; cortisol awakening respons Long-term: • Mortality CoRPS Intervention – web application CoRPS Intervention (fixed, 3-month duration) COMPONENTS TOPICS DEALT WITH Psycho-education about the ICD Emotional reactions to ICD therapy Problem-solving skills Which aspects of ICD therapy may lead to distress Cognitive restructuring Relaxation training How to deal with shocks Disease-specific issues and fears How to prevent the avoidance of Personalized feedback by a therapist activities via the computer Interpretation of bodily symptoms How to cope with uncertainty Help-seeking behavior How to cope with stress CoRPS Advantages of web-based approach • Low-threshold accessibility • Less stigma – no face-to-face meetings with therapists • Obtain treatment at any time and place, work at own pace and review the material as often as desired • No extra hospital visits – being reminded less of illness as the context of the intervention is different CoRPS Clinical and societal relevance • Immediate applicability in health care • Identification of high-risk patients screening • Personalized care optimization of clinical management of device patients • Reduced health-care utilization • Increased cost-effectiveness CoRPS